Correlation Between Pfizer and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pfizer and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Pfizer and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Vertex Pharmaceuticals.
Diversification Opportunities for Pfizer and Vertex Pharmaceuticals
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pfizer and Vertex is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Pfizer i.e., Pfizer and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pfizer and Vertex Pharmaceuticals
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Vertex Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.04 times less risky than Vertex Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Vertex Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 31,640 in Vertex Pharmaceuticals on January 24, 2024 and sell it today you would earn a total of 8,352 from holding Vertex Pharmaceuticals or generate 26.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Pfizer Inc |
| Vertex Pharmaceuticals |
Pfizer and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Vertex Pharmaceuticals
The main advantage of trading using opposite Pfizer and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Pfizer vs. Silver Spike Investment | Pfizer vs. Alkermes Plc | Pfizer vs. Eagle Pharmaceuticals | Pfizer vs. Evotec SE ADR |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |